SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-085738
Filing Date
2021-06-25
Accepted
2021-06-25 16:30:49
Documents
13
Period of Report
2021-06-25
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2120740d1_8k.htm   iXBRL 8-K 51007
2 EXHIBIT 10.1 tm2120740d1_ex10-1.htm EX-10.1 133443
  Complete submission text file 0001104659-21-085738.txt   390800

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA uthr-20210625.xsd EX-101.SCH 3185
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE uthr-20210625_lab.xml EX-101.LAB 34593
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE uthr-20210625_pre.xml EX-101.PRE 22710
6 EXTRACTED XBRL INSTANCE DOCUMENT tm2120740d1_8k_htm.xml XML 3504
Mailing Address 1040 SPRING ST SILVER SPRING MD 20910
Business Address 1040 SPRING ST SILVER SPRING MD 20910 3016089292
UNITED THERAPEUTICS Corp (Filer) CIK: 0001082554 (see all company filings)

IRS No.: 521984749 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-26301 | Film No.: 211048306
SIC: 2834 Pharmaceutical Preparations